Biomodics is an innovative Danish company focusing on bringing to market medical devices that can prevent hospital acquired infections. Biomodics started as a spinout from the large Danish technological company NKT in 2009. Located at the Danish Technology Institute near Copenhagen, Denmark the company has build up a strong patent portfolio of new technologies with great promise in the development of new biofilm-resistant medical devices able to prevent the all too frequent hospital acquired infections. Another focus area for the company is the development of innovative drug delivery solutions. Biomodics also specialises in processes using supercritical CO2 such as purification, extraction, and sterilization.
| Website | http://www.biomodics.com/ |
| Revenue | $6 million |
| Employees | 4 (2 on RocketReach) |
| Founded | 2006 |
| Address | 31 a StengÄrds Allé, Kongens Lyngby, Capital Region 2800, DK |
| Phone | +45 61 66 66 19 |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+6 more
(view full list)
|
| Industry | Medical Devices, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Hospital, Health Care, Information Technology, Medical, Medical Device |
| Competitors | Thermo Fisher Scientific, BD, Merck Group, Agilent Technologies, Waters Corporation, Bio-Rad Laboratories, QIAGEN, Sartorius, Eppendorf Group, Tecan +38 more (view full list) |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular Biomodics ApS employee's phone or email?
The Biomodics ApS annual revenue was $6 million in 2026.
Peter Thomsen is the CEO of Biomodics ApS.
2 people are employed at Biomodics ApS.
Biomodics ApS is based in Kongens Lyngby, Capital Region.
The NAICS codes for Biomodics ApS are [33, 339].
The SIC codes for Biomodics ApS are [384, 38].